Merck to Acquire Immune Design
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/12/2026
- Strong AI earnings lift S&P 500, Nasdaq as inflation data calms rate-hike jitters
- Oil prices little changed as investors weigh lower demand against US-Iran talks deadlock
- CoreWeave soars after fifth straight quarter of record revenue, raised guide
- Four key things investors will watch in Nvidia's earnings next week
- Silver could surge to $90 as investment demand takes over, Citi says
- Lumentum Holdings (LITE) Tops Q4 EPS by 28c, Beats on Revenue; Offers Q1 Guidance
- Crude Inventory Rose 17.2 Million Barrels Last Week - EIA
- Aurora Cannabis rejects Curaleaf's unsolicited $4-per-share takeover bid
- AbCellera Biologics (ABCL) PT Raised to $30 at Truist on 'best-in-class potential'
- Comscore plans restructuring with $20M-$25M in cost cuts
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
- After-Hours Movers: SPCX, AMD, ANET, PINS, APPS, UPST, ZETA, BKNG, LCID, CPNG, MTCH
RBC Capital Downgrades Immune Design (IMDZ) to Sector Perform Following Takeover Deal
February 22, 2019 6:34 AM ESTRBC Capital analyst Brian Abrahams downgraded Immune Design (NASDAQ: IMDZ) from Outperform to Sector Perform with a price target of $6.00 (from $9.00).
The see the acquisition by MRK as highly likely to go through.
For an analyst ratings summary and ratings... More
Immune Design (IMDZ) to be Acquired by Merck for Massive Premium, Shares Surge
February 21, 2019 6:47 AM ESTImmune Design (NASDAQ: IMDZ) to be Acquired by Merck for Massive Premium, Shares Surge
... More